TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography — Stella

Home/Breast Neoplasm Malignant Primary/

View on ClinicalTrials.gov

Recruiting

Back to Breast Neoplasm Malignant Primary trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Norway

St. Olavs hospital, Trondheim

Key details

Sponsor

Norwegian University of Science and Technology

Collaborators

St. Olavs Hospital

Enrollment target

~250 participants

Started

March 2024

Primary completion

December 2026

Age range

18 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.